The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Open accessAbstract
Endemic (Balkan) nephropathy (EN), a devastating renal disease affecting men and women living in rural areas of Bosnia, Bulgaria, Croatia, Romania, and Serbia, is characterized by its insidious onset, invariable progression to chronic renal failure and a strong association with transitional cell (urothelial) carcinoma of the upper urinary tract. Significant epidemiologic features of EN include its focal occurrence in certain villages and a familial, but not inherited, pattern of disease. Our experiments test the hypothesis that chronic dietary poisoning by aristolochic acid is responsible for EN and its associated urothelial cancer. Using 32 P-postlabeling/PAGE and authentic standards, we identified dA-aristolactam (AL) and dG-AL DNA adducts in the renal cortex of patients with EN but not in patients with other chronic renal diseases. In addition, urothelial cancer tissue was obtained from residents of endemic villages with upper urinary tract malignancies. The AmpliChip p53 microarray was then used to sequence exons 2–11 of the p53 gene where we identified 19 base substitutions. Mutations at A:T pairs accounted for 89% of all p53 mutations, with 78% of these being A:T → T:A transversions. Our experimental results, namely, that ( i ) DNA adducts derived from aristolochic acid (AA) are present in renal tissues of patients with documented EN, ( ii ) these adducts can be detected in transitional cell cancers, and ( iii ) A:T → T:A transversions dominate the p53 mutational spectrum in the upper urinary tract malignancies found in this population lead to the conclusion that dietary exposure to AA is a significant risk factor for EN and its attendant transitional cell cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
Vanherweghem, J.-L., Tielemans, C., Abramowicz, D., Depierreux, M., Vanhaelen-Fastre, R., Vanhaelen, M., Dratwa, M., Richard, C., Vandervelde, D., Verbeelen, D., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92984-2 · Cited by 1,076
Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans
Pfohl‐Leszkowicz, A., & Manderville, R. A. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600137 · Cited by 1,017
Oxford textbook of clinical nephrology
Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 716
Oxford Textbook of Clinical Nephrology: Three-Volume Pack
(2015) · doi:10.1093/med/9780199592548.001.0001 · Cited by 511
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Arlt, V. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.4.265 · Cited by 505
Ochratoxin A: The Continuing Enigma
O'Brien, E., & Dietrich, D. R. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590905948 · Cited by 396
Urothelial lesions in Chinese-herb nephropathy
Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., Wese, F.-X., & van Ypersele de Strihou, C. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70136-8 · Cited by 306
Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?
Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., de Plaen, J.-F., Ferluga, D., & Van Ypersele de Strihou, C. (1994) · Kidney International · doi:10.1038/ki.1994.220 · Cited by 297
Aristolochic Acid and ???Chinese Herbs Nephropathy???: A Review of the Evidence to Date
Cosyns, J.-P. (2003) · Drug Safety · doi:10.2165/00002018-200326010-00004 · Cited by 286
Pathologic Aspects of a Newly Described Nephropathy Related to the Prolonged Use of Chinese Herbs
Depierreux, M., Van Damme, B., Vanden Houte, K., & Vanherweghem, J. L. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80178-8 · Cited by 260
Ochratoxin a: Its Cancer Risk and Potential for Exposure
Clark, H. A., & Snedeker, S. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/15287390500195570 · Cited by 189
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser, H. H., Janssen, J. W. G., Lyons, J., Scherf, H. R., Pfau, W., Buchmann, A., Bartram, C. R., & Wießler, M. (1990) · PubMed · Cited by 117
Liu, Z., Hergenhahn, M., Schmeiser, H. H., Wogan, G. N., Hong, A., & Hollstein, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308607101 · Cited by 102
Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™Mouse)
Kohara, A., Suzuki, T., Honma, M., Ohwada, T., & Hayashi, M. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00350-3 · Cited by 76
Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers
Batuman, V. (2006) · Kidney International · doi:10.1038/sj.ki.5000231 · Cited by 63
Schmeiser, H. H., Scherf, H. R., & Wießler, M. (1991) · Cancer Letters · doi:10.1016/0304-3835(91)90178-k · Cited by 57
Feldmeyer, N., Schmeiser, H. H., Muehlbauer, K., Belharazem, D., Knyazev, Y. P., Nedelko, T., & Hollstein, M. C. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.02.017 · Cited by 55
Fink‐Gremmels, J. (2005) · Food Additives & Contaminants · doi:10.1080/02652030500358415 · Cited by 52
Characteristics of Proteinuria in Endemic Nephropathy
Čvoriščec, D., Radonić, M., Čeović, S., et al. (1983) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1983.21.9.569 · Cited by 9
Cited by
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Gontero, P., Van Rhijn, B. W. G., Mostafid, A. H., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.07.036 · Cited by 1,514
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Böhle, A., Van Rhijn, B. W. G., Kaasinen, E., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.06.044 · Cited by 1,341
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Metadata
- Authors
- Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelić, M., & Jelaković, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-07-17
- Volume
- 104
- Issue
- 29
- Pages
- 12129-12134
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2124581521
- Cited by
- 606
- References
- 21
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.